Last Updated: November 16, 2026

Investigational Drug Information for Theanine

« Back to Dashboard


What is the development status for investigational drug Theanine?

Theanine is an investigational drug.

There have been 4 clinical trials for Theanine. The most recent clinical trial was a Phase 2 trial, which was initiated on October 18th 2019.

The most common disease conditions in clinical trials are Problem Behavior, Mental Disorders, and Hyperkinesis. The leading clinical trial sponsors are University of British Columbia, Icahn School of Medicine at Mount Sinai, and Butler Hospital.

There are zero US patents protecting this investigational drug and zero international patents.

Recent Clinical Trials for Theanine
TitleSponsorPhase
L-Theanine to Support Relaxation and Mood for Cancer Patients in SurveillanceNational Cancer Institute (NCI)EARLY_PHASE1
L-Theanine to Support Relaxation and Mood for Cancer Patients in SurveillanceCity of Hope Medical CenterEARLY_PHASE1
Effects of L-theanine on Motor Cortex Excitability in Healthy Subjects: A Paired-Pulse TMS StudyButler HospitalEarly Phase 1

See all Theanine clinical trials

Clinical Trial Summary for Theanine

Top disease conditions for Theanine
Top clinical trial sponsors for Theanine

See all Theanine clinical trials

US Patents for Theanine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Theanine ⤷  Start Trial Method of identifying a biologically-active composition from a biofilm Quorum Innovations Inc ⤷  Start Trial
Theanine ⤷  Start Trial Bioactive compositions from Theacea plants and processes for their production and use ISP INVESTMENTS LLC (Wilmington, DE) ⤷  Start Trial
Theanine ⤷  Start Trial Prevention of micronutrient deficiencies associated with common disabilities in the over 50 adult ⤷  Start Trial
Theanine ⤷  Start Trial Amino acid conjugates of quetiapine, process for making and using the same Zevra Therapeutics Inc ⤷  Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Theanine

Drugname Country Document Number Estimated Expiration Related US Patent
Theanine China CN103687604 2031-03-01 ⤷  Start Trial
Theanine China CN111518866 2031-03-01 ⤷  Start Trial
Theanine European Patent Office EP2680866 2031-03-01 ⤷  Start Trial
Theanine Japan JP2014506923 2031-03-01 ⤷  Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.